HNGE vs MTCH: Which Is the Better Buy in 2026?

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. HNGE and MTCH share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined HNGE and MTCH exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Hinge Health is a digital musculoskeletal (MSK) care platform that provides physical therapy, pain management, and surgery prevention services through a combination of software, connected sensor hardware, and human care teams. The company's core offering combines a mobile and connected-sensor app with personalized exercise therapy programs, behavioral health support, and access to physical therapists, plus care navigation for surgery decisions. Customers are primarily large employers and health plans that purchase Hinge Health benefits for their members.

Full HNGE guide

Match Group is a portfolio of online-dating brands, led by Tinder and Hinge and rounded out by legacy and international apps. It reports in segments that include Tinder, Hinge, Evergreen & Emerging (which houses brands like Match.com, OkCupid, and Plenty of Fish), and Match Group Asia. The business model is largely subscriptions and a la carte paid features, so the numbers that matter are payers (paying users) and revenue per payer across each brand. Tinder is still the single biggest brand and represents more than half of company revenue, which is why its trajectory dominates the story, while Hinge has become the growth engine.

Full MTCH guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• HNGE drivers: Employer benefit penetration; Surgery prevention as ROI driver.
• MTCH drivers: Tinder stabilization and relaunch; Hinge as the growth engine.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Digital health categories are competitive with various platforms targeting MSK and other condition areas. For MTCH, the dominant risk is Tinder's decline: because Tinder is more than half of revenue, continued weakness in its payers and revenue can outweigh Hinge's growth and stall the whole company.

Pick HNGE if you believe its drivers more; MTCH if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the HNGE and MTCH guides.

HNGE. Hinge Health's valuation reflects the digital health growth premium, the demonstrated category leadership in MSK, and the path-to-profitability story. As a recent IPO, valuation is sensitive to broader digital health sector sentiment and to quarterly progression toward profitability.

MTCH. All figures and characterizations here are approximate and tied to the asOf date; verify live numbers, current guidance, and the latest buyback and dividend status before acting. Match Group is a turnaround situation where the valuation depends heavily on whether Tinder stabilizes and Hinge keeps scaling, so free-cash-flow and per-payer trends matter more than any single headline multiple. Treat all metrics as directional and confirm against the most recent filings.

Headline figures (approximate, early 2026): HNGE shows revenue (ttm) ~$400 million (estimated, post-IPO disclosure), operating margin Approaching breakeven; varies by quarter, net income (ttm) Modest GAAP loss; non-GAAP near breakeven, eps (ttm) Near zero; MTCH shows revenue trend Total revenue has been roughly flat, with Hinge's strong double-digit growth offsetting Tinder and legacy-brand declines; management guided to approximately flat total revenue for 2026. Verify live figures before acting., profitability Match is solidly profitable and highly cash-generative, with meaningful operating margins and a large free-cash-flow base; it has flagged payment-processing and cost savings to support margins. Confirm current margins and net income., balance sheet / leverage Match carries debt from its history as an IDG spinout and past deals, offset by strong recurring cash flow; leverage is a factor to watch but the business funds buybacks and a dividend from free cash flow. Verify the latest net-debt position., capital returns Returns cash through share repurchases (planning to retire a meaningful share of the count) and a dividend it has raised. Buybacks are a core part of the per-share story in a flat-revenue year. Check the current buyback authorization and dividend..

HNGE and MTCH are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined HNGE and MTCH exposure against your real portfolio. It is not an investment adviser.